New study aims to map neurofibromatosis in russian adults
NCT ID NCT07088991
First seen Jun 24, 2026 · Last updated Jul 21, 2026 · Updated 4 times
Summary
This study collects information from 200 adults in Russia who have neurofibromatosis type 1 (NF1) with plexiform neurofibromas. Researchers will look at patients' age, symptoms, and medical history to better understand the disease. No new treatments are being tested; the goal is to gather data for future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand neurofibromatosis in adults and improve future care.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly help participants and may not lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGArkhangelsk, Russia
-
Research Site
RECRUITINGChelyabinsk, Russia
-
Research Site
RECRUITINGGrozny, Russia
-
Research Site
RECRUITINGKrasnoyarsk, Russia
-
Research Site
RECRUITINGKurgan, Russia
-
Research Site
RECRUITINGMoscow, Russia
-
Research Site
RECRUITINGNizhny Novgorod, Russia
-
Research Site
RECRUITINGNovosibirsk, Russia
-
Research Site
RECRUITINGOrenburg, Russia
-
Research Site
RECRUITINGPerm, Russia
-
Research Site
RECRUITINGRostov-on-Don, Russia
-
Research Site
RECRUITINGSaint Petersburg, Russia
-
Research Site
RECRUITINGSamara, Russia
-
Research Site
RECRUITINGTomsk, Russia
-
Research Site
RECRUITINGUfa, Russia
-
Research Site
RECRUITINGYekaterinburg, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-World study tracks Selumetinib's impact on NF1 tumors in children
- Could a cholesterol drug boost reading skills in kids with NF1?
- Immune cells take on nerve tumors: new trial launches
- Antioxidant drug shows promise for kids with NF1
- Can a simple walk test spot motor trouble in kids with NF1?
- Could a cancer drug shrink Children's brain tumors?